Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.

Autor:	Goodall, Ruth L1 (AUTHOR) r.goodall@ucl.ac.uk, Meredith, Sarah K1 (AUTHOR), Nunn, Andrew J1 (AUTHOR), Bayissa, Adamu2 (AUTHOR), Bhatnagar, Anuj K3 (AUTHOR), Bronson, Gay4 (AUTHOR), Chiang, Chen-Yuan5,6 (AUTHOR), Conradie, Francesca7 (AUTHOR), Gurumurthy, Meera8 (AUTHOR), Kirenga, Bruce9 (AUTHOR), Kiria, Nana10 (AUTHOR), Meressa, Daniel11 (AUTHOR), Moodliar, Ronelle12 (AUTHOR), Narendran, Gopalan13 (AUTHOR), Ngubane, Nosipho14 (AUTHOR), Rassool, Mohammed15 (AUTHOR), Sanders, Karen1 (AUTHOR), Solanki, Rajesh16 (AUTHOR), Squire, S Bertel17 (AUTHOR), Torrea, Gabriela18 (AUTHOR)
Zdroj:	Lancet. Nov2022, Vol. 400 Issue 10366, p1858-1868. 11p.
Databáze:	Business Source Ultimate
Externí odkaz:	Zobrazit plný text záznamu